• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of Functional Domains of Tissue Factor Pathway Inhibitor

Research Project

Project/Area Number 09680606
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Structural biochemistry
Research InstitutionNational Cardiovascular Center Research Institute

Principal Investigator

KATO Hisao  National Cardiovascular Center Research Institute, Director of Division of Etiology and Pathogenesis, 病因部, 部長 (80029959)

Co-Investigator(Kenkyū-buntansha) HARA Saburo  Kyoto Institute of Technology, Faculty of Engineering and Design, Professor, 繊維学部, 教授 (00028193)
大蔵 直樹  国立循環器病センター研究所, 病因部, 流動研究員
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 1998: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1997: ¥1,500,000 (Direct Cost: ¥1,500,000)
Keywordsprotease inhibitor / blood coagulation / thrombosis / arteriosclerosis / heparin / 抗血栓
Research Abstract

(1) Degradation of TFPI by thrombin
It has been shown that TFPI exists in plasma as a free-form and liporptoein-associated forms and also as truncated forms which were caused by proteolysis. We investigated the actions of various proteases on recombinant TFPI and found that thrombin inactivated the functions of TFPI by secific cleavage of three peptide bonds of TFPI
(2) Interaction of TFPI with heparin
We analyzed the interaction of TEPI with heparin by using modified heparin in which N-sulafate, 2-0-sulfate or 6-0-sulfate residues were specifically removed.and by using shorter chains of polysaccharide. The results indicate that all sulfate residues are essential for the interaction and that sugar chain with 14 units has almost the same ability to interact with TFPI as heparin. We also investigated the interaction of two heparin binding sites of TFPI with heparin. We found that Arg257 and Arg259 were essential for the interaction with heparin by using synthetic peptides with C-terminal basic part. We isolated recombinant K3 domain by Baculo virus system and examined the interaction with heparin.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] N Ohkura: "A novel degradation pathway of tissue factor pathway inhibitor : Incorporation into fibrin clot and degradation by thrombin." BLOOD. 90. 1883-1892 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Z Ye: "Structural requirements of human tissue factor pathway inhibitor(TFPI)and heparin for TFPI-heparin interaction." Thromb Res. 89. 263-270 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 神窪勇一: "血栓と循環" メディカルレビュー社, 8 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] N Ohkuru: "A novel degradation pathway of tissue factor pathway inhibitor : Incorporation into fibrin clot and degradation by thrombin." BLOOD. 90. 1883-1892 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Z Ye: "Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-heparin interaction." Thromb Res. 89. 263-270 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y,Zhiyi,et al.: "Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-Heparin interaction." Thromb.Res.89. 263-270 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 神窪勇一、加藤久雄: "血栓と循環" (株)メディカルレビュー社, 8 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Naoki Ohkura: "A novel degradation pathway of tissue factor pathway inhibitor : Incorporation into fibrin clot and clegradation by thrombin" Blood. 90(5). 1883-1892 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Zhiyi Ye: "Structural requirements of human tissue factor pathway,inhibitor (TFPI) and heparin for TFPI-heparin interaction" Thrcmbosis Research. (in press). (1998)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi